Source/Disclosures
Published by:
Source:
Healio Interview
Disclosures:
Sparks reports receiving research grants to his institution from Bristol-Meyers Squibb, NIH and Rheumatology Research Foundation; and consulting fees from Bristol-Meyers Squibb, Gilead, Inova Diagnostics, Janssen, Optum and Pfizer.
Read next
November 11, 2020
1 min watch
Save
VIDEO: Risk for liver damage may be associated with RA
Source/Disclosures
Published by:
Source:
Healio Interview
Disclosures:
Sparks reports receiving research grants to his institution from Bristol-Meyers Squibb, NIH and Rheumatology Research Foundation; and consulting fees from Bristol-Meyers Squibb, Gilead, Inova Diagnostics, Janssen, Optum and Pfizer.
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this video, Jeffrey A. Sparks, MD, MMSc, associate physician at Brigham and Women's Hospital, explained findings from a study exploring metabolic issues and rheumatoid arthritis.
The study, which was presented at ACR 2020, aimed to “quantify hepatic steatosis,” according to Sparks, who is also an assistant professor of medicine at Harvard Medical School.
“It does seem it’s possible that RA could actually have metabolic consequences that could put patients at risk for liver damage,” he said.
Reference
- Lee J, et al. Abstract #0190. Presented at: ACR Convergence 2020; November 5-9, 2020 (virtual meeting).
Read more about:
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
